Cmbio
Marianne Koliana is an accomplished professional in clinical medicine research and business development, currently serving as Vice President of Business Development at Clinical Microbiomics since November 2019, with prior roles including Director of Key Accounts & Academic Collaborations and Sales and Business Development Manager. Marianne's academic background includes a PhD in Clinical Medicine Research from Imperial College London, where multiple projects in nutrition, microbiome, and metabolic profiling were managed. Additional experience includes a Visiting Scholar position at Emulate, Inc., focused on organ-on-chip technology development, and a research role at Lund University, resulting in a published project on DNA binding dyes for real-time PCR. Educational qualifications include a Master of Science in Biotechnology from both the University of Illinois Urbana-Champaign and Lund University, supplemented by a high school diploma in the Science Program.
This person is not in any teams
Cmbio
Cmbio®, is at the forefront of the human, animal, and planetary health—microbiome science. Formed from the unification of industry leaders like Clinical Microbiomics, CosmosID, MS-Omics, DNASense and Microba’s Research Services, Cmbio® stands as the first global microbiome service and technology company equipped with state-of-the-art multi-omics laboratories and advanced bioinformatics. Our mission is to demystify the complex interplay of the microbiome and its vast influence on health and disease. By integrating applied AI with integrative systems biology, Cmbio® offers unparalleled insights and enterprise solutions that accelerate the pace of discovery and innovation in microbiome research. With GxP-compliant facilities and a robust, scalable software platform, Cmbio® is uniquely positioned to standardize microbiome analysis, ensuring reliability and comparability across global studies. We are committed to advancing scientific understanding and enhancing well-being across all life on our planet. Connect with Cmbio®: Explore how we're making strides in microbiome research and offering cutting-edge solutions to meet the grand challenges of health and sustainability.